Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company dedicated to developing breakthrough therapies via local administration for metastatic and primary cancers to bone and other organs which may provide increased survival rates. Their multi-patented, ZetaMet™ (Zeta-BC-003) therapy is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone with the potential to increase survival rates.
eLux Medical is working towards establishing a novel, technology advances, best-in-class procedure to provide patients and physicians with a safer, less invasive and more effective fat removal procedure. It is intended that patients will demonstrate higher satisfaction scores due to faster recovery times with fewer complications.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.